Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Jinwang Bismuth Industrial is a prominent Chinese metallurgical and chemical company that specializes in the refining and deep processing of bismuth. The company is a vital link in the global pharmaceutical supply chain, manufacturing high-quality bismuth-based active pharmaceutical ingredients (APIs) such as bismuth subcarbonate and bismuth subnitrate. These compounds are widely utilized in the formulation of treatments for gastrointestinal disorders, including peptic ulcers and H. pylori infections. Headquartered in Chenzhou, Hunan, the company leverages its proximity to major bismuth reserves to maintain a significant share of the international market. Despite undergoing financial restructuring starting in 2019, it continues to be recognized for its manufacturing capabilities in the inorganic pharmaceutical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Jinwang Bismuth Industrial.